ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.02
0.54%
US Tech 100
18,986.40
0.30%
Dow Jones
41,393.78
0.72%
Brent Oil
71.825
0.00%
Bitcoin
60,010.53
-0.94%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PAVmed Inc (PAVM) Quote

PAVmed Inc

PAVmed Inc (PAVM)

NASDAQ
1.78
0.0607
(3.53%)
Closed September 14 4:00PM
Delayed by 15 minutes
1.7255
-0.0545
(-3.06%)
After Hours: 7:05PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.7255
Bid
1.68
Ask
1.86
Volume
93,986
1.66 Day's Range 1.8299
0.5999 52 Week Range 145.50
Market Cap
17.956M
Previous Close
1.7193
Open
1.82
Last Trade
6
@
1.76
Last Trade Time
Financial Volume
$ 165,949
VWAP
1.7657
Average Volume (3m)
70,339
Shares Outstanding
10,406,433
Dividend Yield
-
PE Ratio
-0.28
Earnings Per Share (EPS)
-6.37
Revenue
2.45M
Net Profit
-66.27M

About PAVmed Inc

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pavmed.com
Headquarters
Wilmington, Delaware, USA
Founded
-
PAVmed Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker PAVM. The last closing price for PAVmed was $1.72. Over the last year, PAVmed shares have traded in a share price range of $ 0.5999 to $ 145.50.

PAVmed currently has 10,406,433 shares outstanding. The market capitalization of PAVmed is $17.89 million. PAVmed has a price to earnings ratio (PE ratio) of -0.28.

Ask ADVFN Intelligence (AI)

PAVM Latest News

More News

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress PR Newswire NEW YORK...

September 10 2024
PR Newswire (US)

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health PR Newswire NEW YORK, Sept. 3, 2024 Collaboration aims to enhance early detection of esophageal cancer in at-risk...

September 03 2024
PR Newswire (US)

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer PR Newswire NEW YORK, Aug. 20, 2024 Study demonstrates...

August 20 2024
PR Newswire (US)

Form 8-K - Current report

August 13 2024
Edgar (US Regulatory)

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer

The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer PR Newswire NEW YORK, Aug. 13, 2024 Request for insurance...

August 13 2024
PR Newswire (US)

PAVmed Provides Business Update and Second Quarter 2024 Financial Results

PAVmed Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK, Aug. 13, 2024 Lucid reports record quarterly EsoGuard® test volume and held productive meeting with...

August 13 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 12 2024
Edgar (US Regulatory)

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results PR Newswire NEW YORK, Aug. 12, 2024 EsoGuard® test volume increased 31 percent quarterly; 44 percent...

August 12 2024
PR Newswire (US)

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing Event PR Newswire NEW YORK, Aug. 8, 2024 Event held at Fort Worth Fire Department in...

August 08 2024
PR Newswire (US)

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing PR Newswire NEW YORK, Aug. 6, 2024 Real-world data confirms utility of...

August 06 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.0255146.50.71.880.661163201.1883754CS
40.854598.10562571760.8711.880.5999822121.03898131CS
12-0.7245-29.57142857142.452.840.5999703391.4283897CS
26-4.2745-71.241666666766.264750.59991836223.58801488CS
52-119.9245-98.5815865187121.65145.50.599984558934.52100036CS
156-12.9745-88.261904761914.7145.50.5999116809847.43759738CS
2600001.88000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NOVVUNova Vision Acquisition Corporation
$ 41.00
(207.35%)
17.4k
NOVVNova Vision Acquisition Corporation
$ 37.0001
(200.08%)
202.75k
SMXSMX Security Matters Public Company
$ 5.85
(138.78%)
49.72M
OMICSingular Genomics Systems Inc
$ 12.38
(119.12%)
2.72M
TILInstill Bio Inc
$ 84.75
(82.41%)
3.76M
GSIWGarden Stage Ltd
$ 2.9693
(-75.66%)
4.21M
UPCUniverse Pharmaceuticals Inc
$ 0.55
(-67.07%)
29.83M
VMARVision Marine Technologies Inc
$ 0.77
(-48.67%)
30.61M
PRLDPrelude Therapeutics Inc
$ 2.775
(-42.55%)
2.49M
CNEYCN Energy Group Inc
$ 0.4335
(-37.17%)
4.79M
NVDANVIDIA Corporation
$ 119.10
(-0.03%)
238.43M
XXII22nd Century Group Inc
$ 0.3447
(28.00%)
183.73M
IMRXImmuneering Corporation
$ 2.02
(41.26%)
136.36M
SQQQProShares UltraPro Short QQQ
$ 8.17
(-1.33%)
127.78M
MULNMullen Automotive Inc
$ 0.1328
(-20.48%)
120.81M

PAVM Discussion

View Posts
Monksdream Monksdream 3 months ago
PAVM under $2
👍️0
Monksdream Monksdream 7 months ago
PAVM new 52 week low
👍️0
Monksdream Monksdream 9 months ago
PAVM new 52 week low
👍️0
Mattrixinvest Mattrixinvest 12 months ago
Boom
👍️0
Monksdream Monksdream 1 year ago
PAVM new 52 week low
👍️0
Porterhouse10 Porterhouse10 2 years ago
Boom! Haaa
👍️0
Thunderstruck Thunderstruck 3 years ago
PAVM....Why the drop?? wasn't there just good news out in regards to this company and Lucid??
👍️0
Prfmf1 Prfmf1 3 years ago
Looks like they are trying to keep the stock around or under $7.50 to burn the August 20 options holders.
👍️0
TrendTrade2016 TrendTrade2016 3 years ago
not bullish...but bouncing. No microcaps are bullish right now...play with caution!!!
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 3 years ago
$PAVM Chart looking bullish here..
$PAVM Chart starting to show a ton of bullish signs..
Post Masters Telegram Room adding to watchlist..6100 members strong..all are welcome!👇👇https://t.co/V5ZnFIj3Wq https://t.co/d23HODmpWf pic.twitter.com/9ZciTZTJUL— Tommy Boy Trader (@QuabbinR) July 25, 2021
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Was the CEO really arrested last week for fraud? Would it be the first time? Need to do a little more looking at it....right?
👍️0
SurgeGuy2.0 SurgeGuy2.0 3 years ago
Looking good like a stinky pile of crap. PAVM is going nowhere! lolzzzzzzzz
👍️0
bUrRpPPP! bUrRpPPP! 3 years ago
Looking good!
👍️0
Prfmf1 Prfmf1 3 years ago
What are your expectations going forward?
👍️0
TrendTrade2016 TrendTrade2016 3 years ago
PAVM there's a monster breaking out of its chains!!
👍️0
Prfmf1 Prfmf1 3 years ago
Short time PAVM holder and looking for big things to happen with this stock. My average buying price is in the low 4's.
👍️0
Flycanuck Flycanuck 3 years ago
Thanks for the tip. Will have a look .
👍️0
Flycanuck Flycanuck 3 years ago
Got Z warrants and shares too. Have not sold yet. Holding through this run up.
👍️0
rumrunner528 rumrunner528 3 years ago
Thank you, ConstitutionNow.

rum
👍️0
ConstitutionNow ConstitutionNow 3 years ago
Visit stocktwits.com at all? Lots of long term holders on there that have a good pulse on what's happening. I know Lucid spinoff is in the works, 3 clinics in phoenix about to open for eso testing. Eso 'in stock' at like 180 clinics around US. Do some quick numbers on a each test and you can see revs could scale quickly. Throw in nexflo, carpx etc and pavmed could be a great long term investment.
👍️0
rumrunner528 rumrunner528 3 years ago
Good for you, ConstitutionNow. I have z's and shares and have been lightening my position as it's run up. I wish I knew what's going on other than the recent PRs.

rum
👍️0
ConstitutionNow ConstitutionNow 3 years ago
Need a message at the top other than Clay...bad luck anytime he posts. Still sittin on a pile of z warrants...very bright future here! Eso, carpx etc...
👍️0
ClayTrader ClayTrader 3 years ago
* * $PAVM Video Chart 04-06-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Bertsllc Bertsllc 3 years ago
Cantor Fitzgerald analysis upgraded PAVM to overweight with the new target of $8.00.

https://www.benzinga.com/news/21/03/20397441/cantor-fitzgerald-initiates-coverage-on-pavmed-with-overweight-rating-announces-price-target-of-8

👍️0
ConstitutionNow ConstitutionNow 4 years ago
Little late in response here, but good analysis of the latest money raise. Solid move by management to get debt off books, lower dilution and cash leftover to fund commercialization. I think the market is starting to realize it now and we should move north on much more solid ground...where they can raise more cash at prices which don't hurt so much.
👍️0
Flycanuck Flycanuck 4 years ago
from the March 2020 S-3A (link below - page 5), I counted about 14 million shares could have been issued by the convertibles. So actually longer term they have about 4 million shares LESS outstanding plus all the cash you mentioned above. Win / Win.
https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/forms-3a.htm
👍️0
Flycanuck Flycanuck 4 years ago
"PAVmed intends to use the net proceeds from the offering to repay all of the company’s outstanding debt, including all outstanding convertible notes, with the balance to be used for working capital and general corporate purposes."

People don't realize, this doesn't increase dilution. It's a near wash in shares added, becasue the outstanding convertible shares are taken off the books by paying off the convertible holders. It increases float, but not outstanding.

Then the proceeds pay off all other debt, and the company still has around 30M from the offering to use for operations. It's a huge win for the company and shareholders.
👍️0
ClayTrader ClayTrader 4 years ago
* * $PAVM Video Chart 02-22-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
tone3 tone3 4 years ago
Must read article on Seeking Alpha. Target prices from a low of 5.50 up to 12 bucks
👍️0
ConstitutionNow ConstitutionNow 4 years ago
No odea what you are talking about...posted on twitter???????????
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
When will the new Offering/Dilution for 2021 be announced?

Saw it posted on twitter
👍️0
rumrunner528 rumrunner528 4 years ago
Thank you.
👍️0
ConstitutionNow ConstitutionNow 4 years ago
I've dug into those a bit, from what I can tell they are exercisable at a $1.60 a common share. Expire 2024. Slightly more risky than common but not much, if only one of their products take off, imo the warrants are much better investment dollar for dollar.
👍️0
rumrunner528 rumrunner528 4 years ago
👍️0
rumrunner528 rumrunner528 4 years ago
Does anyone know the terms of the PAVMZ warrants? The 10K is very confusing (or perhaps I'm just not that bright).
👍️0
jaj-dan jaj-dan 4 years ago
Gaining lots of credibility here.
👍️0
jaj-dan jaj-dan 4 years ago
PAVmed to join key indexes this month, shares +5% https://seekingalpha.com/news/3583795-pavmed-to-join-key-indexes-this-month-sharesplus-5
👍️0
jaj-dan jaj-dan 4 years ago
News from yesterday. Probably why the price is moving up.

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor https://seekingalpha.com
👍️0
jaj-dan jaj-dan 4 years ago
I was just repeating the talking points from the conference call.
👍️0
Bickema Bickema 4 years ago
"PAVmed had cash and cash equivalents of $8.7 million as of March 31, 2020, compared with $6.2 million as of December 31, 2019. Subsequently, in late April 2020, the Company received approximately $3.6 million in proceeds from a private placement with an institutional investor for the sale of a Senior Secured Convertible Note."

Looks like they $12 million in cash no?
👍️0
Cubzgrl Cubzgrl 4 years ago
Moving north!!!! Lets get back to the $6.00s lol
👍️0
jaj-dan jaj-dan 4 years ago
https://ir.pavmed.com/news-events/press-releases/detail/121/pavmed-collaborates-with-canon-on-disappear-pediatric
👍️0
jaj-dan jaj-dan 4 years ago
PAVMed Is About To Enter The Commercialization Phase https://seekingalpha.com/article/4350867-pavmed-is-to-enter-commercialization-phase
👍️0
tjguy tjguy 4 years ago
Is the European approval of CarpX coming up soon?
👍️0
jaj-dan jaj-dan 4 years ago
I don’t really care if it dips here. There’s plenty of firms targeting this at $9-$10. It’s one of my best positions at the moment. I’m holding.
👍️0
jaj-dan jaj-dan 4 years ago
They didn’t really have much to say on the call. They were impacted by the virus with elective surgeries being postponed. They also commented that esoguard could be spun off into another company to raise money
👍️0
jaj-dan jaj-dan 4 years ago
There was only 1 analyst on the call. That’s not good. Management sounded very competent answering questions
👍️0
elcheepo elcheepo 4 years ago
thats a lot of cash they burned... they need to slow down
👍️0
jaj-dan jaj-dan 4 years ago
They said that their CarpX device will make 80-85% return
👍️0
jaj-dan jaj-dan 4 years ago
Re: PAVM
Some people may have bought hoping for a partnership deal announced. These things take time. You won't get a great deal if you are in a hurry.
👍️0

Your Recent History

NASDAQ
PAVM
PAVmed
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved